Cite
HARVARD Citation
Bertani, L. et al. (n.d.). OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY. Digestive and liver disease. pp. S73-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bertani, L. et al. (n.d.). OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY. Digestive and liver disease. pp. S73-. [Online].